DIN 02542560 — HEMGENIX 10000000000000 GENOME COPIES
HEMGENIX is a suspension of Etranacogene dezaparvovec marketed by CSL BEHRING CANADA INC. The full Etranacogene dezaparvovec monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02542560
- Brand name
- HEMGENIX
- Active ingredient
- Etranacogene dezaparvovec
- Strength
- 10000000000000 GENOME COPIES
- Dosage form
- SUSPENSION
- Route
- INTRAVENOUS
- Manufacturer
- CSL BEHRING CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Adeno-associated virus vector-based gene therapy (Factor IX gene therapy)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.